You are here: Industry Insights > Apotex

News List

Apotex Issues Voluntary Nationwide Recall of Drospirenone, Ethinyl Estradiol Tablets americanpharmaceuticalreview
March 06, 2019
Apotex is voluntarily recalling four lots of Drospirenone and Ethinyl Estradiol Tablets, USP to the patient /user level.
Aurobindo acquires Apotex’s operations in five European countries expressbpd
February 12, 2019
The company had inked a binding agreement on July 14, 2018
Strides, Apotex merge their Australian business biospectrumasia
May 11, 2018
The merged entity will be Australia's largest generic maker
Apotex President resigns amidst Founder's murder and allegations of accepting Teva secrets pharmafile
January 31, 2018
Following the alleged murder of its founder Barry Sherman and his wife in December last year, Canada’s largest generic drug producer Apotex has now lost its President and CEO, as Jeremy Desai resigns effective immediately, to “pursue other opportunities.
Apotex to expand footprint in India expressbpd
August 02, 2017
Opens global business services office in Mumbai
Apotex Announces $184M Investment to Grow U.S. Manufacturing Presence americanpharmaceuticalreview
March 09, 2017
Apotex has announced the details of a $184 million U.S. expansion plan, including the development of a new R&D center and advanced manufacturing and packaging facility that will serve as the U.S. headquarters for Apotex Corp.
Apotex Spends $184mn to Grow U.S. Mfg. Presence contractpharma
March 09, 2017
Advanced R&D, manufacturing, and packaging facility to serve as U.S. HQ

Previous page 1 2 Next page